JP2012041314A - 脳腫瘍治療用キット及び脳腫瘍治療方法 - Google Patents

脳腫瘍治療用キット及び脳腫瘍治療方法 Download PDF

Info

Publication number
JP2012041314A
JP2012041314A JP2010185691A JP2010185691A JP2012041314A JP 2012041314 A JP2012041314 A JP 2012041314A JP 2010185691 A JP2010185691 A JP 2010185691A JP 2010185691 A JP2010185691 A JP 2010185691A JP 2012041314 A JP2012041314 A JP 2012041314A
Authority
JP
Japan
Prior art keywords
brain tumor
tumor treatment
olanzapine
cimetidine
treatment method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010185691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012041314A5 (https=
Inventor
Mitsutoshi Nakata
光俊 中田
Toshishige Minamoto
利成 源
Yutaka Hayashi
裕 林
Junichiro Hamada
潤一郎 濱田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanazawa University NUC
Original Assignee
Kanazawa University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanazawa University NUC filed Critical Kanazawa University NUC
Priority to JP2010185691A priority Critical patent/JP2012041314A/ja
Publication of JP2012041314A publication Critical patent/JP2012041314A/ja
Publication of JP2012041314A5 publication Critical patent/JP2012041314A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2010185691A 2010-08-22 2010-08-22 脳腫瘍治療用キット及び脳腫瘍治療方法 Pending JP2012041314A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010185691A JP2012041314A (ja) 2010-08-22 2010-08-22 脳腫瘍治療用キット及び脳腫瘍治療方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010185691A JP2012041314A (ja) 2010-08-22 2010-08-22 脳腫瘍治療用キット及び脳腫瘍治療方法

Publications (2)

Publication Number Publication Date
JP2012041314A true JP2012041314A (ja) 2012-03-01
JP2012041314A5 JP2012041314A5 (https=) 2013-09-12

Family

ID=45898028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010185691A Pending JP2012041314A (ja) 2010-08-22 2010-08-22 脳腫瘍治療用キット及び脳腫瘍治療方法

Country Status (1)

Country Link
JP (1) JP2012041314A (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014214126A (ja) * 2013-04-25 2014-11-17 学校法人金沢医科大学 膵臓癌治療剤
WO2019093379A1 (ja) * 2017-11-07 2019-05-16 学校法人自治医科大学 ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途
KR20190141554A (ko) * 2018-06-14 2019-12-24 연세대학교 산학협력단 암의 예방 또는 치료용 약학적 조성물
CN115252622A (zh) * 2022-09-26 2022-11-01 中日友好医院(中日友好临床医学研究所) 醛糖还原酶阻化剂及其在制备用于治疗肺癌的药物中的应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6014032334; 中田光俊: 日本脳神経外科学会総会抄録集（ＣＤ-ＲＯＭ） , 20090914, Ｎｏ．１Ｂ-Ｓ０４-０２ *
JPN6014032335; Ｍｉｙａｓｈｉｔａ　Ｋ: Ｃｌｉｎ　Ｃａｎｃｅｒ　Ｒｅｓ Ｖｏｌ．１５, 2009, ｐｐ．８８７-８９７ *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014214126A (ja) * 2013-04-25 2014-11-17 学校法人金沢医科大学 膵臓癌治療剤
WO2019093379A1 (ja) * 2017-11-07 2019-05-16 学校法人自治医科大学 ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途
US11369615B2 (en) 2017-11-07 2022-06-28 Jichi Medical University Agent for improving mitochondrial dysfunction, preventative or therapeutic agent for diseases or symptoms caused by mitochondrial dysfunction, and applications therefor
KR20190141554A (ko) * 2018-06-14 2019-12-24 연세대학교 산학협력단 암의 예방 또는 치료용 약학적 조성물
KR102205656B1 (ko) * 2018-06-14 2021-01-21 연세대학교 산학협력단 암의 예방 또는 치료용 약학적 조성물
CN115252622A (zh) * 2022-09-26 2022-11-01 中日友好医院(中日友好临床医学研究所) 醛糖还原酶阻化剂及其在制备用于治疗肺癌的药物中的应用
CN115252622B (zh) * 2022-09-26 2023-02-21 中日友好医院(中日友好临床医学研究所) 醛糖还原酶阻化剂及其在制备用于治疗肺癌的药物中的应用

Similar Documents

Publication Publication Date Title
Armando et al. New drugs are not enough-drug repositioning in oncology: An update
Pan et al. Wedelolactone facilitates Ser/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis
Kalogris et al. Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition
Rana et al. Small molecule adenosine 5′-monophosphate activated protein kinase (AMPK) modulators and human diseases
EP3038652B1 (en) Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases
Tsubaki et al. Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model
Lu et al. Transient receptor potential ankyrin 1 activation within the cardiac myocyte limits ischemia-reperfusion injury in rodents
US20230190754A1 (en) Therapeutic combinations for the treatment of Progressive Fibrosing interstitial lung diseases
Zhu et al. CaMK II inhibition attenuates ROS dependent necroptosis in acinar cells and protects against acute pancreatitis in mice
JP2015525063A (ja) 低酸素状態に基づくｈｓｐ９０インヒビターでの治療のための被験者の予備選択
Sasaki et al. Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model
Martinez-Carreres et al. Cancer: linking powerhouses to suicidal bags
Li et al. The role of mitochondrial dynamin in stroke
CN113453671A (zh) 用于治疗癌症的Raf抑制剂和CDK4/6抑制剂的组合疗法
JP2012041314A (ja) 脳腫瘍治療用キット及び脳腫瘍治療方法
AU2025205402A1 (en) New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases
JP5930204B2 (ja) 癌細胞アポトーシス
KR101565430B1 (ko) N-메틸렌나프토[2,1-b]퓨란-2-카보하이드라지드 유도체를 유효성분으로 포함하는 암 예방 또는 치료용 조성물
US20250000852A1 (en) Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma
Holstein et al. Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia
Xu et al. Ponatinib-induced ichthyosiform drug eruption: insights into acquired ichthyosis
KR101532211B1 (ko) Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물 및 방법
Sampat et al. Inhibitors of the p21 activated kinases
SULEIMAN The role of P90 ribosomal S6 kinase and autophagy in sunitinib and ponatinib-induced cardiotoxicity
CN113648310A (zh) Gsk872在制备治疗脑出血后神经细胞损伤的药物中的应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130729

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130729

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140804

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141202